Comparison of emergency department patient classification by point-of-care and central laboratory methods for cardiac

Jay L Bock1, Adam J Singer, Henry C Thode

  • 1Department of Pathology, Stony Brook University, Stony Brook, NY 11794-7300, USA.

Insights

Rapid point-of-care whole blood cardiac troponin I testing generally aligns with central laboratory plasma assays for acute coronary syndrome. However, it may miss minor elevations and produce some false positives.

Area of Science:

  • Clinical diagnostics
  • Cardiovascular medicine
  • Biomarker analysis

Background:

  • Acute coronary syndrome (ACS) diagnosis relies on cardiac troponin I (cTnI) levels.
  • Point-of-care testing (POCT) offers rapid results but requires validation against central laboratory assays.

Purpose of the Study:

  • To compare the diagnostic performance of a rapid, whole blood POCT assay for cTnI against a central laboratory plasma assay.
  • To evaluate the reliability of POCT for patient classification in emergency department settings.

Main Methods:

  • Prospective comparison of Abbott i-STAT whole blood cTnI (Tn-P) with Siemens TnI-Ultra plasma assay (Tn-U) in emergency department patients with suspected ACS.
  • Retesting of elevated Tn-P results and a random selection of negative Tn-P results using Tn-U.

Main Results:

  • Of 5,909 initial Tn-P tests, 573 (9.7%) were elevated. Of these, 4.5% retested negative by Tn-U.
  • The Tn-U assay generally yielded higher results (approx. 50%) and had a lower 99th percentile cutoff than Tn-P.
  • 5.8% of initially negative Tn-P results retested as elevated by Tn-U, with low levels (<0.1 ng/mL).

Conclusions:

  • Rapid whole blood cTnI POCT provides generally reliable patient classification compared to central laboratory plasma assays.
  • The POCT assay may miss subtle elevations in cTnI and can produce false positives, necessitating careful interpretation.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Effects of EDTA on End-Point Detection Methods01:18

Effects of EDTA on End-Point Detection Methods

Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...